Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody. | Antibodies (Basel) | 2023 | 37489369 | PubTator, text mining | PubMed |
| Diagnostic, clinicopathological features and prognostic value of B7x expression in Chinese women with breast cancer: A meta-analysis. | Asian J Surg | 2023 | 37481357 | PubTator, text mining | PubMed |
| Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition. | NPJ Precis Oncol | 2023 | 37468567 | PubTator, text mining | PubMed |
| Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma. | Front Immunol | 2023 | 37457742 | PubTator, text mining | PubMed |
| Tetraspanin CD63 reduces the progression and metastasis of head and neck squamous cell carcinoma via KRT1-mediated cell cycle arrest. | Heliyon | 2023 | 37455999 | PubTator, text mining | PubMed |
| Immunotherapy for Recurrent Glioma-From Bench to Bedside. | Cancers (Basel) | 2023 | 37444531 | PubTator, text mining | PubMed |
| Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways. | Cancers (Basel) | 2023 | 37444481 | PubTator, text mining | PubMed |
| Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models. | Cancers (Basel) | 2023 | 37444459 | PubTator, text mining | PubMed |
| Inferring regulators of cell identity in the human adult pancreas. | NAR Genom Bioinform | 2023 | 37435358 | PubTator, text mining | PubMed |
| The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review. | J Gastrointest Oncol | 2023 | 37435208 | PubTator, text mining | PubMed |
| Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435203 | PubTator, text mining | PubMed |
| Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy. | Front Oncol | 2023 | 37427115 | PubTator, text mining | PubMed |
| Efficient and scalable generation of primordial germ cells in 2D culture using basement membrane extract overlay. | Cell Rep Methods | 2023 | 37426764 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy. | Front Immunol | 2023 | 37426676 | PubTator, text mining | PubMed |
| Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer. | Front Immunol | 2023 | 37426654 | PubTator, text mining | PubMed |
| Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer. | Medicine (Baltimore) | 2023 | 37417594 | PubTator, text mining | PubMed |
| Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma. | PLoS One | 2023 | 37405988 | PubTator, text mining | PubMed |
| Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer. | Front Immunol | 2023 | 37404825 | PubTator, text mining | PubMed |
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. | Biomark Res | 2023 | 37403120 | PubTator, text mining | PubMed |
| METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment. | Sci Rep | 2023 | 37400463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=18